慢性病和脆弱性骨折患者的死亡率:重新审视GFR值
Joany Mariño1,2, Paula Strittmatter3, Maik Gollasch3,4
1Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.
European geriatric medicine
|August 17, 2025
概括
在患有脆弱性骨折的老年人中,估计的小球膜过率 (eGFR) 低于45毫升/分钟/1.73平方米,表明死亡风险更高,结果较差. 轻度至中度的CKD (eGFR 45-59) 在这组患者中没有表现出不良影响.
科学领域:
- 老年学是一门学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 整形外科 整形外科 整形外科
背景情况:
- 慢性病 (CKD) 在老年人中很普遍,但它对脆弱性骨折患者的影响尚不清楚.
- 在老年人群中轻度至中度CKD (eGFR 45-59 ml/min/1.73 m2) 的临床意义需要进一步研究.
研究的目的:
- 为了检查不同的估计膜过率 (eGFR) 类别和orthogeriatric患者的结果之间的关联.
- 为了确定eGFR水平 (<45,45-59和≥60毫升/分钟/1.73米2) 对死亡率和功能恢复的预后值.
主要方法:
- 一项回顾性队列研究,涉及2015年至2023年期间入院的453名正正老年患者.
- 患者在入院时根据eGFR进行分类:<45,45-59和≥60毫升/分钟/1.73米2.
- 评估的结果包括死亡率,住院并发症,功能恢复和脆弱性调解.
主要成果:
- 患有eGFR<45毫升/分钟/1.73米2的患者表现出更差的基线功能,更多的并发症和更差的恢复.
- 对于eGFR<45组 (HR 1.77) 的人来说,长期全因死亡率显著更高.
- 与EGFR ≥60组相比,EGFR 45-59组显示出类似或更好的结果,包括死亡率.
结论:
- 一个eGFR<45毫升/分钟/1.73米2识别 orthogeriatric 患者增加不良结果的风险.
- 在45-59毫升/分钟/1.73米2之间的eGFR水平与该人群的更差预后没有关联.
- 较低的CKD诊断值可能对患有脆弱性骨折的老年人更具有临床意义.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
160
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
160
Chronic Kidney Disease III: Interprofessional Care
80
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
Acute Kidney Injury III: Clinical Manifestations
94
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94
Chronic Kidney Disease I: Introduction
67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
Chronic Kidney Disease II: Clinical Manifestations
91
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
91
Acute Kidney Injury I: Introduction
74
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
74


